CRSP insider trading — Crispr Therapeutics AG
Over the last 90 days, insiders at Crispr Therapeutics AG (CRSP) made 0 open-market purchases worth $0 and 3 open-market sales worth $1.03M, making them net sellers by $1.03M. The largest sale was by Behbahani Ali (Director), who sold 13,679 shares for $781K on Sep 17, 2026.
Updated Oct 16, 2026.
Recent CRSP insider transactions
Every Form 4 filed by Crispr Therapeutics AG officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 14, 2026 | Kulkarni Samarth | Chief Executive Officer | S · Sale | Direct | 4,098 | $49.26 | $202K | Form 4 |
| Oct 14, 2026 | Kasinger James R. | General Counsel and Secretary | S · Sale | Direct | 1,040 | $49.26 | $51K | Form 4 |
| Oct 13, 2026 | Kulkarni Samarth | Chief Executive Officer | M · Option exercise | Direct | 8,333 | — | — | Form 4 |
| Oct 13, 2026 | Kasinger James R. | General Counsel and Secretary | M · Option exercise | Direct | 2,113 | — | — | Form 4 |
| Oct 6, 2026 | Kasinger James R. | General Counsel and Secretary | M · Option exercise · 10b5-1 | Direct | 1,990 | $13.62 | $27K | Form 4 |
| Oct 6, 2026 | Kasinger James R. | General Counsel and Secretary | S · Sale · 10b5-1 | Direct | 1,990 | $60.04 | $119K | Form 4 |
| Sep 22, 2026 | Kasinger James R. | General Counsel and Secretary | M · Option exercise · 10b5-1 | Direct | 10,400 | $13.62 | $142K | Form 4 |
| Sep 22, 2026 | Kasinger James R. | General Counsel and Secretary | S · Sale · 10b5-1 | Direct | 10,400 | $60.24 | $626K | Form 4 |
| Sep 17, 2026 | Behbahani Ali | Director | M · Option exercise | Direct | 30,000 | $14.00 | $420K | Form 4 |
| Sep 17, 2026 | Behbahani Ali | Director | S · Sale | Direct | 13,679 | $57.09 | $781K | Form 4 |
| Aug 6, 2025 | Behbahani Ali | Director | J · Other | Direct | 60 | — | — | Form 4 |
| Aug 6, 2025 | Behbahani Ali | Director | J · Other | Indirect | 15 | — | — | Form 4 |
| Aug 7, 2026 | Prasad Raju | Chief Financial Officer | G · Gift | Direct | 750 | — | — | Form 4 |
CRSP insider trading FAQ
Are insiders buying CRSP stock?
Not on the open market. In the last 90 days, Crispr Therapeutics AG insiders made no open-market purchases, and 3 open-market sales totaling $1.03M. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading CRSP?
Recent sellers: Behbahani Ali, Kasinger James R., Kulkarni Samarth.
Where does CRSP insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.